Actinobacteria and Myxobacteria : Important Resources for Novel Antibiotics

• Autore: Wink Joachim
• Pubblicazione: Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
• Descrizione fisica: 1 electronic resource (270 p.)
• Soggetto topico: Research & information: general; Biology, life sciences
• Soggetto non controllato: actinomycetes; antibiotic biosynthesis; silent biosynthetic pathways; γ-butyrolactones; HiTES; translation inhibitors; marine actinobacteria; Streptomyces sp; enzyme inhibition; antimicrobial; antioxidant; cytotoxicity; GC-MS; pyrrolopyrazines; myxobacteria; antivirals; secondary metabolites; HIV; Ebola; hepatitis viruses; diversity; uncultured; new antibiotics; Streptomyces; polyketides; secondary metabolite; polyketide synthases (PKSs)
• Persona (resp. second.): WinkJoachim
• Sommario/riassunto: Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units.
• Altri titoli varianti: Actinobacteria and Myxobacteria
• Titolo autorizzato: Actinobacteria and Myxobacteria
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910557422303321
• Lo trovi qui: Univ. Federico II